TrialClinical and vaccine immunology : CVI2016

Evaluation of the Safety, Tolerability, and Immunogenicity of an Oral, Inactivated Whole-Cell Shigella flexneri 2a Vaccine in Healthy Adult Subjects.

Subhra Chakraborty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.